OXiGENE To Participate In The S.G. Cowen & Company 6th Annual Global Healthcare Conference

WALTHAM, Mass.--(BUSINESS WIRE)--Nov. 3, 2005--OXiGENE, Inc. (NASDAQ: OXGN, XSSE: OXGN), a leading developer of biopharmaceutical compounds to treat cancer and certain ophthalmologic diseases, announced today that Frederick Driscoll, its President and Chief Executive Officer, will present at the S.G. Cowen & Co. 6th Annual Global Healthcare Conference at the Hilton Diagonal Mar in Barcelona, Spain. Mr. Driscoll will present on Thursday, November 10, 2005 at 4:55 p.m. local time, 10:55 a.m. EST. A live and archived webcast of the presentation can be accessed by visiting http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker= OXGN&item_id=1149778. (Due to the length of this URL, it may be necessary to copy and paste it into your Internet browser’s URL address field. You may also need to remove an extra space in the URL if one exists.) The webcast will be archived for 90 days.

MORE ON THIS TOPIC